[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Bruce Robinson, MD\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":50},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":5},"100593765","phase-1-treating-basal-and-squamous-cell-carcinomas-with-fractional-laser-and-tirbanibulin-ointment-100593765",false,"NCT07010692","Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment","Using Fractional Lasers and Tirbanibulin Ointment to Treat Keratinocyte Carcinomas","Inclusion Criteria: biopsy confirmed squamous and\u002For basal cell carcinoma not previously treated by another method.\n\nExclusion Criteria:\n\n* Cannot be pregnant at the time of treatment","ALL","18 Years",{"count":19,"type":20},100,"ESTIMATED","INTERVENTIONAL",[23,24],"PHASE1","PHASE2","The investigators seek to evaluate the effectiveness of fractional laser therapy and tirbanibulin ointment to treat squamous and basal cell carcinomas. This will be executed by using both thulium and erbium lasers on previously biopsy-confirmed SCCs and BCCs and applying bulk heating methods. Then, depending on the level of invasiveness, subjects may be instructed to apply the ointment over the course of five nights immediately following the treatment. The intention of this study is to minimize the need for invasive surgical procedures so as to optimize the cosmetic appearance, and provide a treatment option that is beneficial for a wide range of individuals.",[27,28,29,30],"Keratinocyte Carcinoma","Basal Cell Carcinomas","Squamous Cell Carcinoma","Skin Cancer",[32,29,33,34,35,36,37],"Basal Cell Carcinoma","BCC","SCC","keratinocyte carcinoma","skin cancer","laser treatment","RECRUITING","2025-09-15",{"date":41,"type":42},"2025-09-17","ACTUAL",{"date":44,"type":42},"2025-05-16",{"date":46,"type":20},"2030-06",{"name":48,"class":49},"Bruce Robinson, MD","OTHER",""]